Industry Influences Distort Healthcare Research, Strategy, Expenditure and Practice


Researchers from London, Sydney and Stanford examine the literature related to the expanded expenditure on healthcare-related drugs and devices over the last 15 years, finding an “abundance of consistent evidence demonstrating that the industry has created means to intervene in all steps of the processes that determine healthcare research, strategy, expenditure, practice and education. As a result of these interferences, the benefits of drugs and other products are often exaggerated and their potential harms are downplayed, and clinical guidelines, medical practice, and healthcare expenditure decisions are biased.” Results appear in the European Journal of Clinical Investigation.

Article →

Stamatakis, E., Weiler, R., Loannidis, J.; Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. European Journal of Clinical InvestigationMay 2013, Vol 43(5)469-75

Previous articleRelative Risk of Brain Tissue Loss From Relapse/Antipsychotics
Next articleDispatches from a Reluctant Guide
on the Path to Disability
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].